escitalopram - Cardinal Health 107, LLC

Manufacturer
Cardinal Health 107, LLC
Effective date
2026-04-27
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
19
Source
full-release
Hydrated at
2026-05-31 22:18:02

Key Label Information#

Uses

1 INDICATIONS AND USAGE

4 CONTRAINDICATIONS

Warnings

4 CONTRAINDICATIONS

5 WARNINGS AND PRECAUTIONS

Directions And Dosage

2 DOSAGE AND ADMINISTRATION

3 DOSAGE FORMS AND STRENGTHS

10 OVERDOSAGE

Other Label Information

16 HOW SUPPLIED/STORAGE AND HANDLING

Package/Label Display Panel

NDC 55154-6893-0 ESCITALOPRAM TABLETS, USP 10 mg 10 TABLETS

Package/Label Display Panel

NDC 55154-7288-0 ESCITALOPRAM TABLETS, USP 20 mg 10 TABLETS

Label Images#

aa1ecae7-8a57-434f-a72b-088335b1a42c-04
aa1ecae7-8a57-434f-a72b-088335b1a42c-04
aa1ecae7-8a57-434f-a72b-088335b1a42c-03
aa1ecae7-8a57-434f-a72b-088335b1a42c-03
aa1ecae7-8a57-434f-a72b-088335b1a42c-02
aa1ecae7-8a57-434f-a72b-088335b1a42c-02
6dd4eb62-4211-41c7-8592-69c0b045b53f-01
6dd4eb62-4211-41c7-8592-69c0b045b53f-01
6dd4eb62-4211-41c7-8592-69c0b045b53f-00
6dd4eb62-4211-41c7-8592-69c0b045b53f-00

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
349332escitalopram oxalate 10 MG Oral TabletPSN19
351250escitalopram oxalate 20 MG Oral TabletPSN19
349332escitalopram 10 MG Oral TabletSCD19
351250escitalopram 20 MG Oral TabletSCD19
349332escitalopram (as escitalopram oxalate) 10 MG Oral TabletSY19
351250escitalopram (as escitalopram oxalate) 20 MG Oral TabletSY19

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ESCITALOPRAM Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
04dce598-23c6-b7e7-c3dd-9b9cfd6e1615Product name620170718

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
55154-6893-0escitalopram10 in 1 BAGTABLET, FILM COATED1019
55154-6893-0escitalopram1 in 1 BLISTER PACKTABLET, FILM COATED119
55154-7288-0escitalopram1 in 1 BLISTER PACKTABLET, FILM COATED119
55154-7288-0escitalopram10 in 1 BAGTABLET, FILM COATED1019

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0904-6426-61EA - Each0904-6426d251f1ea-d5c0-4eaa-8850-ba2262c5607712014-11-05
0904-6427-61EA - Each0904-6427caeae26c-18c7-4615-bf04-8fa617bc60e312014-11-05

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
ESCITALOPRAM OXALATEACTIVE INGREDIENT5U85DBW7LO2
ESCITALOPRAMACTIVE MOIETY4O4S742ANY2
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61U2
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH482
HYPROMELLOSE 2910 (6 MPA.S)INACTIVE INGREDIENT0WZ8WG20P62
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I302
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQ2
POVIDONE K12INACTIVE INGREDIENT333AG72FWJ2
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU42
TALCINACTIVE INGREDIENT7SEV7J4R1U2
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JP2

Products#

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
55154-689355154-6893-0
0904-6426
55154-728855154-7288-0
0904-6427

Ingredients#

Complete SPL Sections#

1 INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

2 DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

3 DOSAGE FORMS AND STRENGTHS

DOSAGE FORMS & STRENGTHS SECTION

4 CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

5 WARNINGS AND PRECAUTIONS

WARNINGS AND PRECAUTIONS SECTION

6 ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

7 DRUG INTERACTIONS

DRUG INTERACTIONS SECTION

8 USE IN SPECIFIC POPULATIONS

USE IN SPECIFIC POPULATIONS SECTION

9 DRUG ABUSE AND DEPENDENCE

DRUG ABUSE AND DEPENDENCE SECTION

10 OVERDOSAGE

OVERDOSAGE SECTION

11 DESCRIPTION

DESCRIPTION SECTION

12 CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

13 NONCLINICAL TOXICOLOGY

NONCLINICAL TOXICOLOGY SECTION

14 CLINICAL STUDIES

CLINICAL STUDIES SECTION

16 HOW SUPPLIED/STORAGE AND HANDLING

HOW SUPPLIED SECTION

17 PATIENT COUNSELING INFORMATION

INFORMATION FOR PATIENTS SECTION

Medication Guide

SPL MEDGUIDE SECTION

MEDICATION GUIDE Escitalopram (es" sye tal' oh pram) Tablets, USP What is the most important information I should know about escitalopram tablets? Escitalopram tablets may cause serious side effects, including: • Increased risk of suicidal thoughts or actions. Escitalopram tablets and other antidepressant medicines increase the risk of suicidal thoughts and actions in people 24 years of age and younger, especially within the first few months of treatment or when the dose is changed. o Depression or other mental illnesses are the most important causes of suicidal thoughts or actions. How can I watch for and try to prevent suicidal thoughts and actions? o Pay close attention to any changes, especially sudden changes in mood, behavior, thoughts, or feelings, or if you or your child develop suicidal thoughts or actions. This is very important when an antidepressant medicine is started or when the dose is changed. o Call your healthcare provider right away to report new or sudden changes in mood, behavior, thoughts, or feelings or if you or your child develop suicidal thoughts or actions. o Keep all follow-up visits with your healthcare provider as scheduled and call your healthcare provider between visits if you are worried about symptoms. Call your healthcare provider or get emergency medical help right away if you or your child have any of the following symptoms, especially if they are new, worse, or worry you: • attempts to commit suicide • acting on dangerous impulses • acting aggressive, being angry or violent • thoughts about suicide or dying • new or worse depression • new or worsening anxiety • panic attacks • feeling very agitated or restless • new or worse irritability • trouble sleeping • an extreme increase in activity or talking (mania) • other unusual changes in behavior or mood What is escitalopram tablets? Escitalopram tablets are prescription medicine used to treat: • a certain type of depression called Major Depressive Disorder (MDD) in adults and children 12 years of age and older • Generalized Anxiety Disorder (GAD) in adults It is not known if escitalopram is safe and effective for use in children under 12 years of age with MDD or children under 7 years of age with GAD. Do not take escitalopram tablets if you or your child: • are taking, or have stopped taking within the last 14 days, a medicine called a monoamine oxidase inhibitor (MAOI), including the antibiotic linezolid or intravenous methylene blue • are taking the antipsychotic medicine pimozide • are allergic to escitalopram or citalopram or any of the ingredients in escitalopram tablets. See the end of this Medication Guide for a complete list of ingredients in escitalopram tablets. Ask your healthcare provider or pharmacist if you are not sure if you or your child take an MAOI, including the antibiotic linezolid or intravenous methylene blue. Do not start taking an MAOI for at least 14 days after you or your child have stopped treatment with escitalopram tablets. Before taking escitalopram tablets, tell your healthcare provider about all your medical conditions, including if you or your child : • have or had seizures or convulsions • have, or have a family history of bipolar disorder, mania, or hypomania • have low blood sodium levels • have or had bleeding problems • have high pressure in the eye (glaucoma) • have heart, liver, or kidney problems • are pregnant or plan to become pregnant. Escitalopram tablets may harm the unborn baby. Taking escitalopram tablets during the third trimester of pregnancy may cause the baby to have withdrawal symptoms, or breathing, temperature control, feeding, or other problems after birth. Talk to your healthcare provider about the risks to the baby if you or your child take escitalopram tablets during pregnancy. o Tell your healthcare provider right away if you or your child become pregnant or think you may be pregnant during treatment with escitalopram tablets. o There is a pregnancy registry for females who are exposed to escitalopram tablets during pregnancy. The purpose of the registry is to collect information about the health of females exposed to escitalopram tablets and their baby. If you or your child become pregnant during treatment with escitalopram tablets, talk to your healthcare provider about registering with the National Pregnancy Registry for Antidepressants at 1-844-405-6185 or visit online at https://womensmentalhealth.org/research/pregnancyregistry/antidepressants. • are breastfeeding or plan to breastfeed. Escitalopram passes into breast milk and may harm the baby. Talk to your healthcare provider about the best way to feed the baby during treatment with escitalopram tablets. o If you or your child breastfeed during treatment with escitalopram tablets, call your healthcare provider if the baby develops sleepiness or fussiness, or is not feeding or gaining weight well. Tell your healthcare provider about all the medicines you or your child take, including prescription and nonprescription medicines, vitamins, and herbal supplements. Escitalopram tablets and some medicines may affect each other and may cause serious side effects. Escitalopram tablets may affect the way other medicines work and other medicines may affect the way Escitalopram tablets works. Especially tell your healthcare provider if you take: • medicines used to treat migraine headache known as triptans • tricyclic antidepressants • lithium • tramadol, fentanyl, meperidine, methadone, or other opioids • tryptophan • buspirone • amphetamines • St. John’s Wort • medicines used to treat mood, anxiety, psychotic or thought disorders, including selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs) • diuretics • medicines that can affect blood clotting such as aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs) and warfarin Ask your healthcare provider if you are not sure if you or your child are taking any of these medicines. Your healthcare provider can tell you if it is safe to take escitalopram tablets with your other medicines. Do not start or stop any other medicines during treatment with escitalopram tablets without talking to your healthcare provider first. Stopping escitalopram tablets suddenly may cause you or your child to have serious side effects. See, “What are the possible side effects of Escitalopram tablets?” Know the medicines you or your child take. Keep a list of them to show your healthcare provider and pharmacist when you get new medicine. How should I take Escitalopram tablets? • Take escitalopram tablets exactly as prescribed. Your healthcare provider may need to change the dose of escitalopram tablets until it is the right dose for you or your child. • Take escitalopram tablets 1 time each day, in the morning or the evening. • Take escitalopram tablets with or without food. • If you or your child take too much escitalopram tablets, call your healthcare provider or Poison Help Line at 1-800-222-1222, or go to the nearest hospital emergency room right away. What should I avoid while taking escitalopram tablets? • Do not drive, operate heavy machinery, or do other dangerous activities until you know how escitalopram tablets affects you. Escitalopram tablets can cause sleepiness or may affect your ability to make decisions, think clearly, or react quickly. • Do not drink alcohol during treatment with escitalopram tablets. What are the possible side effects of escitalopram tablets? Escitalopram tablets may cause serious side effects, including: • See “What is the most important information I should know about escitalopram tablets?” • Serotonin syndrome. A potentially life-threatening problem called serotonin syndrome can happen when escitalopram tablets is taken with certain other medicines. See “Do not take escitalopram tablets if you?” Call your healthcare provider or go to the nearest hospital emergency room right away if you or your child have any of the following signs and symptom...

Package/Label Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 55154-6893-0 ESCITALOPRAM TABLETS, USP 10 mg 10 TABLETS

Package/Label Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 55154-7288-0 ESCITALOPRAM TABLETS, USP 20 mg 10 TABLETS

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
182026-03-10monthly-update2026-06-03 17:59:52